Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

ERYTHROMYCIN C CRS (25 MG)

ERYTHROMYCIN C CRS (25 MG)

1675-02-1

DISCOVER
Eprosartan mesylate

Eprosartan mesylate

144143-96-4

DISCOVER
Exemestan

Exemestan

107868-30-4

DISCOVER
ERYTHROMYCIN ESTOLATE CRS (100 MG)

ERYTHROMYCIN ESTOLATE CRS (100 MG)

3521-62-8

DISCOVER
Erdosteine

Erdosteine

84611-23-4

DISCOVER
Epichlorhydrin D5

Epichlorhydrin D5

69533-54-6

DISCOVER
Erythromycin D3

Erythromycin D3

NA

DISCOVER
ERYTHROMYCIN ETHYLSUCCINATE CRS (10 MG)

ERYTHROMYCIN ETHYLSUCCINATE CRS (10 MG)

1264-62-6

DISCOVER
ERYTHROMYCIN STEARATE CRS (50MG)

ERYTHROMYCIN STEARATE CRS (50MG)

643-22-1

DISCOVER
17beta-Estradiol-2,4,16,16 D4

17beta-Estradiol-2,4,16,16 D4

66789-03-5

DISCOVER
ERYTHROPOIETIN BRP (6 MG)

ERYTHROPOIETIN BRP (6 MG)

11096-26-7

DISCOVER
Epiandrosterone

Epiandrosterone

481-29-8

DISCOVER